Anti–β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623

The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis

Jüni, P. (1999) · JAMA · doi:10.1001/jama.282.11.1054 · Cited by 1,981

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

Galli, M., Barbui, T., Comfurius, P., Maassen, C., Hemker, H. C., Zwaal, R. F. A., Bevers, E. M., Baets, M. H. D., & Vriesman, P. J. C. V. B. (1990) · The Lancet · doi:10.1016/0140-6736(90)91374-j · Cited by 1,266

Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH.

Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164

Criteria for the Diagnosis of Lupus Anticoagulants: An Update: On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH

Brandt, J. T., Triplett, D. A., Alving, B., & Scharrer, I. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649901 · Cited by 993

Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature

Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972

The “Primary” Antiphospholipid Syndrome

Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963

The "primary" antiphospholipid syndrome: major clinical and serological features.

Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

Matsuura, E., Igarashi, Y., Fujimoto, M., Ichikawa, K., & Koike, T. (1990) · The Lancet · doi:10.1016/0140-6736(90)91697-9 · Cited by 718

Laboratory diagnosis and management challenges in the antiphospholipid syndrome

Bertolaccini, M. L., & Khamashta, M. A. (2006) · Lupus · doi:10.1191/0961203306lu2293rr · Cited by 47

Antiphospholipid antibodies: Paradigm in transition

Horstman, L. L., Jy, W., Bidot, C., Ahn, Y. S., Kelley, R. E., Zivadinov, R., Maghzi, A. H., Etemadifar, M., Mousavi, S. A., & Minagar, A. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-3 · Cited by 46

Detection of Antiphosphatidylserine/Prothrombin Antibodies and Their Potential Diagnostic Value

Žigon, P., Čučnik, S., Ambrožič, A., Kveder, T., Šemrl, S. S., Rozman, B., & Božič, B. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/724592 · Cited by 45

Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases

SWADŹBA, J., IWANIEC, T., SZCZEKLIK, A., & MUSIAŁ, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02669.x · Cited by 44

The thrombophilic network of autoantibodies in celiac disease

Lerner, A., Agmon‐Levin, N., Shapira, Y., Gilburd, B., Reuter, S., Lavi, I., & Shoenfeld, Y. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-89 · Cited by 44

Antiphospholipid antibodies and the protein C pathway

Urbanus, R. T., & de Laat, B. (2010) · Lupus · doi:10.1177/0961203309360841 · Cited by 44

Platelets express three different splice variants of ApoER2 that are all involved in signaling

Pennings, M. T. T., Derksen, R. H. W. M., Urbanus, R. T., Tekelenburg, W. L. H., Hemrika, W., & de Groot, P. G. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02605.x · Cited by 44

Antiphospholipid (Hughes) Syndrome

Khamashta, M. A., Bertolaccini, M. L., & Hughes, G. R. V. (2004) · Autoimmunity · doi:10.1080/08916930410001708706 · Cited by 44

Laboratory Evaluation of Hypercoagulability

Khor, B., & Cott, E. M. V. (2009) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2009.03.002 · Cited by 43

Inhibition of Nitric Oxide and Antiphospholipid Antibody-Mediated Thrombosis

Mineo, C. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0324-4 · Cited by 43

Epidemiology of the Antiphospholipid Syndrome

Durcan, L., & Petri, M. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00002-8 · Cited by 43

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome

Meneghel, L., Ruffatti, A., Gavasso, S., Tonello, M., Mattia, E., Spiezia, L., Tormene, D., Hoxha, A., Fedrigo, M., & Simioni, P. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.04.033 · Cited by 42

The role of TLR 4 in pathophysiology of antiphospholipid syndrome‐associated thrombosis and pregnancy morbidity

Xie, H., Sheng, L., Zhou, H., & Yan, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12587 · Cited by 43

Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission

Bidot, C., Jy, W., Horstman, L. L., Ahn, E. R., Jimenez, J. J., Yaniz, M., Lander, G., & Ahn, Y. S. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05314.x · Cited by 42

Predictive, protective, orphan autoantibodies: The example of anti-phospholipid antibodies

Meroni, P. L., & Shoenfeld, Y. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.08.001 · Cited by 42

The association of antiphospholipid antibodies with pregnancy-related first time venous thrombosis – a population-based case-control study

Bergrem, A., Jacobsen, E., Skjeldestad, F. E., Jacobsen, A. F., Skogstad, M., & Sandset, P. M. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2009.12.006 · Cited by 41

New Tests to Detect Antiphospholipid Antibodies: Antiprothrombin (aPT) and Anti-Phosphatidylserine/Prothrombin (aPS/PT) Antibodies

Sciascia, S., Khamashta, M. A., & Bertolaccini, M. L. (2014) · Current Rheumatology Reports · doi:10.1007/s11926-014-0415-x · Cited by 41

Antiprothrombin antibody: why do we need more assays?

Atsumi, T., & Koike, T. (2010) · Lupus · doi:10.1177/0961203310361487 · Cited by 40

Diagnosis of antiphospholipid syndrome

Bertolaccini, M. L., Khamashta, M. A., & Hughes, G. R. V. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0017 · Cited by 40

Anti-β2-glycoprotein I antibodies—When and how should they be measured?

Reber, G., & de Moerloose, P. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.034 · Cited by 40

IgA antiphospholipid antibodies are an independent risk factor for thromboses

Shen, Y., Lee, R., Frenkel, E., & Sarode, R. (2008) · Lupus · doi:10.1177/0961203308093460 · Cited by 39

Treatment of the antiphospholipid syndrome

Galli, M. (2013) · Autoimmunity Highlights · doi:10.1007/s13317-013-0056-5 · Cited by 38

Prothrombin conversion is accelerated in the antiphospholipid syndrome and insensitive to thrombomodulin

Kremers, R., Zuily, S., Kelchtermans, H., Peters, T. C., Bloemen, S., Regnault, V., Hemker, H. C., de Groot, P. G., Wahl, D. G., & de Laat, B. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018018036 · Cited by 38

Revision of the Sapporo criteria for the antiphospholipid syndrome – Coming to grips with evidence and Thomas Bayes?

Peetz, D., von Landenberg, P., & Lackner, K. J. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-03-0132 · Cited by 38

The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method

Meneghel, L., Ruffatti, A., Gavasso, S., Tonello, M., Mattia, E., Spiezia, L., Campello, E., Hoxha, A., Fedrigo, M., Punzi, L., et al. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2014-0925 · Cited by 37

Consensus guidelines on anti-beta 2 glycoprotein I testing and reporting

Wong, R. C. W., Favaloro, E. J., Adelstein, S., Baumgart, K. W., Bird, R. J., Brighton, T., Empson, M. B., Gillis, D., Hendle, M. J., Laurent, R., et al. (2007) · Pathology · doi:10.1080/00313020701717720 · Cited by 37

Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE

Domingues, V., Magder, L. S., & Petri, M. (2016) · Lupus Science & Medicine · doi:10.1136/lupus-2015-000107 · Cited by 36

Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays

Favaloro, E. J., & Wong, R. C. W. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.064 · Cited by 36

The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome

Yin, D., de Laat, B., Devreese, K. M. J., & Kelchtermans, H. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.06.011 · Cited by 36

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

Tsutsumi, A., Hayashi, T., Chino, Y., Mamura, M., Goto, D., Matsumoto, I., Ito, S., & Sumida, T. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0481-7 · Cited by 36

Prognostic impact of anticardiolipin antibodies in women with recurrent miscarriage negative for the lupus anticoagulant

Nielsen, H. S., & Christiansen, O. B. (2005) · Human Reproduction · doi:10.1093/humrep/deh790 · Cited by 36

Inherited and Acquired Thrombophilias

Rambaldi, M. P., Mecacci, F., Guaschino, S., & Paidas, M. J. (2013) · Reproductive Sciences · doi:10.1177/1933719113497282 · Cited by 35

Antiphospholipid syndrome: critical analysis of the diagnostic path

Pengo, V., Banzato, A., Bison, E., Denas, G., Jose, S. P., & Ruffatti, A. (2010) · Lupus · doi:10.1177/0961203309360543 · Cited by 35

Antiphospholipid Antibodies and Risk for Recurrent Vascular Events—Reply

Levine, S. R., Brey, R. L., Tilley, B. C., Triplett, D. A., Thompson, J. L. P., Sacco, R. L., Mohr, J. P., & for the APASS Investigators, F. T. A. I. (2004) · JAMA · doi:10.1001/jama.291.22.2702 · Cited by 35

Anti-β2-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss

Alijotas‐Reig, J., Ferrer‐Oliveras, R., Rodrigo-Anoro, M. J., Farrán-Codina, I., Cabero, L., & Vilardell, M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.089 · Cited by 34

Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?

Bardin, N., Alessi, M., Dignat‐George, F., Juhan-Vague, I., Sampol, J., Harle, J. ‐., & Sanmarco, M. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.02.001 · Cited by 34

Recurrent Miscarriage, Antiphospholipid Antibodies and the Risk of Thromboembolic Disease

Martínez‐Zamora, M. Á., Cervera, R., & Balasch, J. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8316-0 · Cited by 33

Laboratory tests for the antiphospholipid syndrome: current concepts

Passam, F. H., & Krilis, S. A. (2004) · Pathology · doi:10.1080/00313020410001671966 · Cited by 33

Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis

Hasegawa, M., Sato, S., Yanaba, K., Komura, K., Yamazaki, M., & Takehara, K. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016659 · Cited by 33

A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome

Pengo, V. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02965.x · Cited by 33

Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule

Girardi, G., & Mackman, N. (2008) · Lupus · doi:10.1177/0961203308094994 · Cited by 32

Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio

Amory, C. F., Levine, S. R., Brey, R. L., Gebregziabher, M., Tuhrim, S., Tilley, B. C., Simpson, A.-C. C., Sacco, R. L., Mohr, J. P., & Collaborators, F. T. A.-W. (2015) · Cerebrovascular Diseases · doi:10.1159/000441362 · Cited by 31

Recent developments in our understanding of the antiphospholipid syndrome

de Groot, P. G., Meijers, J. C. M., & Urbanus, R. T. (2012) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2012.01414.x · Cited by 31

Arginine Residues Are Important in Determining the Binding of Human Monoclonal Antiphospholipid Antibodies to Clinically Relevant Antigens

Giles, I., Lambrianides, N., Pattni, N., Faulkes, D. J., Latchman, D. S., Chen, P. P., Pierangeli, S. S., Isenberg, D. A., & Rahman, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1729 · Cited by 31

The effect of phospholipids on the formation of immune complexes between autoantibodies and β2-glycoprotein I or prothrombin

Bevers, E. M., Zwaal, R. F. A., & Willems, G. M. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.02.009 · Cited by 31

Utility of current thrombophilia screening in young patients with stroke and TIA

Alakbarzade, V., Taylor, A. E., Scully, M., Simister, R. J., & Chandratheva, A. (2018) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000169 · Cited by 30

Criteria for the diagnosis of antiphospholipid syndrome in patients presenting with dermatologic symptoms

Kriseman, Y. L., Nash, J. W., & Hsu, S. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.11.033 · Cited by 30

Obstetric antiphospholipid syndrome

Esteve‐Valverde, E., Ferrer‐Oliveras, R., & Alijotas‐Reig, J. (2015) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2015.11.003 · Cited by 29

Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort

Heikal, N., Jaskowski, T. D., Malmberg, E. M., Lakos, G., Branch, D. W., & Tebo, A. E. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12573 · Cited by 29

The antiphospholipid triangle

Galli, M. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03689.x · Cited by 29

Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)

Pengo, V., Denas, G., Bison, E., Banzato, A., Jose, S. P., Gresele, P., Marongiu, F., Erba, N., Veschi, F., Ghirarduzzi, A., et al. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.05.018 · Cited by 29

Clinical Significance of Anticardiolipin and Anti-β2-Glycoprotein I Antibodies

Obermoser, G., Bitterlich, W., Kunz, F., & Sepp, N. T. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000080658 · Cited by 29

Antibodies against domain I of β2-glycoprotein I: the one and only?

Pelkmans, L., & de Laat, B. (2012) · Lupus · doi:10.1177/0961203312437439 · Cited by 28

The clinical relevance of the IgM isotype of antiphospholipid antibodies in the vascular antiphospholipid syndrome

Del Ross, T., Ruffatti, A., Cuffaro, S., Tonello, M., Calligaro, A., Favaro, M., Facchinetti, M., Hoxha, A., & Punzi, L. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.08.019 · Cited by 27

Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I

Wahezi, D. M., Nt, I., Xx, W., Pelkmans, L., de Laat, B., Schanberg, L. E., Rand, J., & for the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators (2013) · Lupus · doi:10.1177/0961203313490241 · Cited by 27

Thrombophilia and Hypercoagulability

Hassouna, H. I. (2009) · Medical Principles and Practice · doi:10.1159/000235891 · Cited by 27

Antiphospholipid antibodies: update on detection, pathophysiology, and treatment

de Groot, P. G., & Derksen, R. H. W. M. (2004) · Current Opinion in Hematology · doi:10.1097/01.moh.0000130313.95291.4a · Cited by 27

Anticoagulating patients with high-risk acquired thrombophilias

Skeith, L. (2018) · Blood · doi:10.1182/blood-2018-05-848697 · Cited by 26

Tick-borne diseases and autoimmunity: A comprehensive review

Rodríguez, Y., Rojas, M., Gershwin, M. E., & Anaya, J. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.11.007 · Cited by 26

Antiphospholipid Antibody Testing: Which Are Most Useful for Diagnosis?

Bertolaccini, M. L., & Hughes, G. R. V. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.05.001 · Cited by 26

Antiprothrombin antibodies: a comparative analysis of homemade and commercial methods. A collaborative study by the Forum Interdisciplinare per la Ricerca nelle Malattie Autoimmuni (FIRMA).

Tincani, A., Morozzi, G., Afeltra, A., Alessandri, C., Allegri, F., Bistoni, O., Bizzaro, N., Caccavo, D., Galeazzi, M., Gerli, R., et al. (2007) · PubMed · Cited by 25

Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detects low avidity antibodies

Žigon, P., Ambrožič, A., Čučnik, S., Kveder, T., Rozman, B., & Božič, B. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.162 · Cited by 25

Pathogenesis of the antiphospholipid syndrome revisited: time to challenge the dogma

Lackner, K. J., & Müller‐Calleja, N. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13320 · Cited by 24

Antibodies to prothrombin

Bertolaccini, M. L. (2012) · Lupus · doi:10.1177/0961203312443299 · Cited by 23

Síndrome antifosfolipídico obstétrico

Esteve‐Valverde, E., Ferrer‐Oliveras, R., & Alijotas‐Reig, J. (2015) · Revista Clínica Española · doi:10.1016/j.rce.2015.09.003 · Cited by 23

Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice

Galli, M. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083810 · Cited by 23

Accuracy of the First Fully Automated Method for Anti‐cardiolipin and Anti‐β2 Glycoprotein I Antibody Detection for the Diagnosis of Antiphospholipid Syndrome

Villalta, D., Alessio, M. G., Tampoia, M., Re, A., Stella, S., Re, M., Tozzoli, R., & Bizzaro, N. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04659.x · Cited by 22

Prevalence and clinical correlates of anti‐phospholipid antibodies in South Africans with systemic lupus erythematosus

Gould, T., Tikly, M., Asherson, R. A., Loizou, S., & Singh, S. (2006) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740510026913 · Cited by 22

The Future of Antiphospholipid Antibody Testing

de Groot, P. G., & Urbanus, R. T. (2012) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0032-1304715 · Cited by 22

Correlation of Livedo Racemosa, Cutaneous Inflammatory Plaques, and Antiphospholipid Antibodies in Patients With Cutaneous Polyarteritis Nodosa

Kawakami, T., & Soma, Y. (2011) · Medicine · doi:10.1097/md.0b013e3182115508 · Cited by 22

Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?

Galli, M. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.009 · Cited by 22

Single or triple positivity for antiphospholipid antibodies in “carriers” or symptomatic patients: Untangling the knot

Bertin, D., Camoin‐Jau, L., Veit, V., Resseguier, N., Lambert, M., Buffet Delmas, P., Heim, X., Mège, J., Morange, P., & Bardin, N. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15518 · Cited by 21

Dos and don'ts in diagnosing antiphospholipid syndrome

Rand, J. H., & Wolgast, L. R. (2012) · Hematology · doi:10.1182/asheducation.v2012.1.455.3806865 · Cited by 21

Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome

Zhang, S., Wu, Z., Zhang, W., Zhao, J., Norman, G. L., Zeng, X., Zhang, F., & Li, Y. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0811 · Cited by 21

Antiphospholipid Syndrome and Thrombosis

Branch, D. W., & Eller, A. (2006) · Clinical Obstetrics & Gynecology · doi:10.1097/01.grf.0000211955.61121.3b · Cited by 21

The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies

Membré, A., Wahl, D. G., Latger‐Cannard, V., Max, J., Lacolley, P. J., Lecompte, T., & Regnault, V. (2008) · Haematologica · doi:10.3324/haematol.12364 · Cited by 21

A Review of ß 2 -Glycoprotein-l Antibody Testing Results From a Peer-Driven Multilaboratory Quality Assurance Program

Favaloro, E. J., Wong, R. C. W., Jovanovich, S., & Roberts-Thomson, P. J. (2007) · American Journal of Clinical Pathology · doi:10.1309/l78kj01chqm4mk37 · Cited by 21

Management of Antiphospholipid Antibody Syndrome

Lim, W., & Crowther, M. A. (2008) · Wiley eBooks · doi:10.1002/9781444300857.ch21 · Cited by 21

Therapeutic Approaches to Secondary Immune Thrombocytopenic Purpura

Bussel, J. B. (2009) · Seminars in Hematology · doi:10.1053/j.seminhematol.2008.12.003 · Cited by 20

The Clinical Relevance of Noncriteria Antiphospholipid Antibodies

Sanna, G., & Bertolaccini, M. L. (2017) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0037-1601328 · Cited by 20

Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis

Sidelmann, J. J., Sjøland, J. A., Gram, J., Bertelsen, V., Mourits‐Andersen, T., Münster, H., Münster, A. B., & Jespersen, J. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601038992 · Cited by 20

ORIGINAL ARTICLE: Are Anti‐Beta2‐Glycoprotein‐I Antibodies Markers for Recurrent Pregnancy Loss in Lupus Anticoagulant/Anticardiolipin Seronegative Women?

Alijotas‐Reig, J., Casellas‐Caro, M., Ferrer‐Oliveras, R., Llurba, E., Hermosilla, E., Vilardell, M., & Cabero, L. (2008) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2008.00618.x · Cited by 19

Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.

Hasegawa, M., Fujimoto, M., Hayakawa, I., Matsushita, T., Nishijima, C., Yamazaki, H., Takehara, K., & Sato, S. (2006) · PubMed · Cited by 19

Prevalence and isotype distribution of antiphospholipid antibodies in unselected Chilean patients with venous and arterial thrombosis

Palomo, I. F., Pereira, J. I., Alarcón, M. A., V�squez, M., Pinochet, C., V�lez, M. T., Sandoval, J. I., Icaza, G., & Pierangeli, S. S. (2004) · Clinical Rheumatology · doi:10.1007/s10067-003-0846-7 · Cited by 19

Current Debates in Antiphospholipid Syndrome: The Acquired Antibody-Mediated Thrombophilia

Öztürk, M. A., Haznedaroğlu, İ. C., Turgut, M., & Göker, H. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000201 · Cited by 19

An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus

Hisada, R., & Atsumi, T. (2023) · Biomolecules · doi:10.3390/biom13040617 · Cited by 18

Antibodies against acute phase proteins and their functions in the pathogenesis of disease: A collective profile of 25 different antibodies

Lakota, K., Žigon, P., Mrak‐Poljšak, K., Rozman, B., Shoenfeld, Y., & Sodin‐Šemrl, S. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.06.001 · Cited by 18

Diagnostic algorithm for thrombophilia screening

Margetić, S. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.362 · Cited by 18

Chapter 2 Epidemiology of the Antiphospholipid Syndrome

Mehrani, T., & Petri, M. (2009) · Technical report · doi:10.1016/s1571-5078(08)00402-9 · Cited by 18

Immune Thrombocytopenia in Patients with Connective Tissue Disorders and the Antiphospholipid Antibody Syndrome

Arkfeld, D. G., & Weitz, I. C. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.08.010 · Cited by 18

Antiphospholipid syndrome presenting as cerebral venous sinus thrombosis: a case series and a review

Shlebak, A. A. (2015) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2015-203077 · Cited by 19

Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa

Kawakami, T., Yamazaki, M., Mizoguchi, M., & Soma, Y. (2008) · Rheumatology · doi:10.1093/rheumatology/kep036 · Cited by 18

The antiphospholipid syndrome: clinical characteristics, laboratory features and pathogenesis

de Groot, P. G., & Derksen, R. H. W. M. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000168379.01272.53 · Cited by 18

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases)

Gerosa, M., Chighizola, C. B., & Meroni, P. L. (2008) · Internal and Emergency Medicine · doi:10.1007/s11739-008-0170-y · Cited by 18

Therapeutic Potential of Toleragens in the Management of Antiphospholipid Syndrome

Cockerill, K. A., Iverson, G. M., Jones, D. S., & Linnik, M. D. (2004) · BioDrugs · doi:10.2165/00063030-200418050-00002 · Cited by 18

Deciphered coagulation profile to diagnose the antiphospholipid syndrome using artificial intelligence

Kremers, R., Wahl, D. G., Zuily, S., Ninivaggi, M., Chayouâ, W., Regnault, V., Musiał, J., de Groot, P. G., Devreese, K. M. J., & de Laat, B. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.05.008 · Cited by 17

Laboratory Evaluation of Antiphospholipid Antibodies in Patients With Venous Thromboembolism

Hirmerová, J., Ulcova-Gallova, Z., Seidlerová, J., Filipovský, J., Bibková, K., Mičanová, Z., & Mayer, O. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029608331228 · Cited by 17

Evaluation of a new silica clotting time in the diagnosis of lupus anticoagulants

Devreese, K. M. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2006.10.015 · Cited by 17

Characterization of monoclonal anti-β2-glycoprotein-I and anti-prothrombin antibody fragments generated by phage display from a patient with primary antiphospholipid syndrome

Languren, M., Becerril, B., Cabral, A. R., Fernández-Altuna, L. E., Pascual, V., Hernández‐Ramírez, D. F., & Cabiedes, J. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.10.002 · Cited by 17

Antiphospholipid antibodies in a large population-based cohort: genome-wide associations and effects on monocyte gene expression

Müller‐Calleja, N., Rossmann, H., Müller, C., Wild, P. S., Blankenberg, S., Pfeiffer, N., Binder, H., Beutel, M. E., Manukyan, D., Zeller, T., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0947 · Cited by 16

Antiphospholipid antibodies and thrombosis: strength of association

Galli, M., & Barbui, T. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200206 · Cited by 61

A prospective study of antibodies to β2‐glycoprotein I and prothrombin, and risk of thrombosis

FORASTIERO, R., MARTINUZZO, M., POMBO, G., PUENTE, D., ROSSI, A., CELEBRIN, L., BONACCORSO, S., & AVERSA, L. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01295.x · Cited by 170

Antiphospholipid Syndrome: Association Between Laboratory Tests and Clinical Practice

Galli, M. (2003) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000083810 · Cited by 23

Antiphospholipid antibodies in systemic lupus erythematosus and the antiphospholipid syndrome

Yatish, N. S. (2001) · Frontiers in bioscience · doi:10.2741/setty · Cited by 8

Mechanisms of thrombosis in systemic lupus erythematosus and antiphospholipid syndrome

de Groot, P. G., & de Laat, B. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.09.008 · Cited by 62